Evolution of Prognostic Scoring Systems for MDS

The diagnosis and treatment of myelodysplastic syndromes (MDS) has moved on dramatically in the few three decades. From across the globe, pioneers in the recognition and understanding of MDS pulled together to collaborate and push forward this research laying the foundations of where we are today.

VJHemOnc were delighted to catch up with four of these pioneers to discuss their research – taking us from inception to future outlooks. Chaired by Amer Zeidan, MBBS, MHS, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, this roundtable discussion included a prestigious panel in the world of MDS – Ghulam Mufti, OBE, DM, FRCP, FRCPath, King’s College London, London, Peter Greenberg, MD, Stanford University Medical Center, Stanford, CA, Mario Cazzola, MD, University of Pavia, Italy and John M. Bennett, MD, University of Rochester Medical Center, Rochester, NY.

The post The MDS Sessions: Giants in MDS appeared first on VJHemOnc.